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Breast-feeding is a route of transmission of HIV from an infected mother to her infant.  However, breast-feeding is an
important pillar of child survival and the ideal way of feeding an infant, as well as providing a unique biological and
emotional basis for child development.  This article highlights the dilemma created by the risks and benefits of breast-
feeding and will discuss factors that increase the risk of HIV transmission during breast-feeding as well as strategies that
could be employed to reduce these risks.  Many questions remain unanswered.
The subject of breast-feeding and HIV has become a highly
emotive debate because of the polarisation between those
whose mandate is preventing the spread of HIV, and
therefore stress the importance of replacing breast-
feeding, and those whose mandate is child survival, and
therefore promote breast-feeding as one of the pillars of
child survival.
DURATION OF BREAST-FEEDING
Since the advent of polymerase chain reaction (PCR)
testing it has been possible to determine the risk of HIV
transmission via breast-feeding more accurately.  To date
there has only been one randomised controlled clinical trial
(RCT) of breast-feeding versus formula; however, the study
had a serious limitation in terms of lack of compliance with
the assigned feeding mode.  This Kenyan study found a risk
of transmission of 16% by age 24 months.1 It is unlikely
that any groups in the future will attempt an RCT of
feeding practices, as the Kenyan trial showed that it is very
difficult to randomise a behaviour, like breast-feeding, that
is so inherently part of a woman's motherhood.
Furthermore, it is now generally agreed that it would be
unethical to repeat such a trial. In order to determine the
risk of breast-feeding transmission more accurately, the
Breastfeeding and HIV International Transmission Study
(BHITS) Group2 therefore conducted an individual patient
data meta-analysis of 4 085 predominantly breast-fed
children who participated in nine RCTs testing the effect of
nutrients or antiretroviral drugs to prevent mother-to-
child transmission of HIV (PMTCT). By definition, any HIV
infection detected by PCR after 4 weeks of age was
attributed to breast-feeding transmission.  The probability
of breast-feeding transmission of HIV was estimated to be
9.3% at 18 months, and the overall risk of breast-feeding
transmission was estimated as 8.9 transmissions/100 child-
years of breast-feeding, which is interpreted as a monthly
risk of 0.74% per month of breast-feeding. The meta-
analysis demonstrated that the risk of transmission was
cumulative and roughly constant throughout the breast-
feeding period. A suggested figure to work with is therefore
a 4% risk for every 6 months of breast-feeding.
PATTERN OF BREAST-FEEDING
Most studies attempting to estimate the transmission of
HIV attributable to breast-feeding have made no attempt
to define the pattern of breast-feeding. Just as it is
important to specify the duration of breast-feeding when
assigning risk, so too is it important to specify the type of
breast-feeding that is practised. In most studies
insufficient information has been collected to enable
infants to be classified as receiving exclusive breast-
feeding (EBF) or breast-milk in addition to other liquids
and/or solids in the first 6 months (mixed breast-fed).
Many researchers have used arbitrary definitions of EBF
and not the accepted World Health Organisation (WHO)
definition, which defines EBF as breast-milk only, with no
other solids or liquids.  The only prospective study that used
the correct definition of RBF was conducted in Durban.3 In
this study3 HIV-infected women who chose to breast-feed
were encouraged to practise EBF as a possible way of
reducing risk of HIV infection.  The study found that the
cumulative probability of HIV infection was similar among
never-breast-fed and EBF infants up to 6 months, i.e.
19.4% (95% CI: 13.6 - 26.0) and 19.4% (95% CI: 12.5 -
27.4), respectively, but it was higher in the mixed breast-
fed group, i.e. 26.1% (95% CI 20.5 - 31.9). The results of this
study suggest that the vertical transmission of HIV through
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breast-milk is dependent on the pattern of breast-feeding
and not simply on breast-feeding per se.  A limitation of the
study was measuring adherence to the reported feeding
practice.  Measuring adherence will always be difficult and
future studies have been encouraged to incorporate
frequent monitoring, in order to improve the validity of the
maternal recall.   
Several, large, well-designed, prospective cohort studies in
South Africa, Zimbabwe, Cote d'Ivoire and Zambia are
currently in progress to examine more closely the effect of
EBF on the risk of breast-feeding transmission.  Preliminary
results of the Zimbabwean4 and Cote d’Ivoire5 studies
presented at the International AIDS Conference in Bangkok,
(July 2004) have confirmed the finding that exclusive
breast-feeding carries a much lower risk of HIV transmission
than mixed breast-feeding.
Considerable evidence suggests that breast-feeding may be
associated with maternal health benefits.6 These include
decreased postpartum bleeding and decreased menstrual
blood loss during the months following labour; delayed
resumption of ovulation with increased child-spacing;
improved postpartum bone remineralisation and decreased
postmenopausal hip fractures; and decreased rates of
ovarian and breast cancer.  
In contrast to these maternal health benefits, Nduati and
colleagues reported that 24-month maternal mortality
among breast-feeding HIV-seropositive mothers they
followed up in Kenya was significantly increased relative to
formula-feeding counterparts.7 The accompanying
commentary by Newell8 pointed out that the data needed
to be interpreted with caution because of limitations in the
study.  Furthermore, the results of this study were
dissimilar to the results of the Durban study,9 which failed
to show an increase in either mortality or morbidity in the
breast-feeding group.
Following the reporting of these two studies, the WHO
convened an expert meeting and concluded that there was
insufficient evidence to suggest that breast-feeding by
HIV-infected women increases their mortality risk.10
Subsequent to this WHO statement, a Tanzanian study,11 a
Zambian study,12 and a meta-analysis involving nine large
studies13 have shown clearly that breast-feeding does not
pose any mortality or other health risk to the HIV-infected
mother. 
MORBIDITY AND MORTALITY RISKS OF NOT BREAST-
FEEDING
As mentioned earlier, simply encouraging women not to
breast-feed in order to prevent postnatal transmission of
HIV is not straightforward, as not breast-feeding carries its
own risks. The objective of any PMTCT strategy must be to
optimise overall child survival, including that of children of
HIV-uninfected women. Central to this decision is
determining the risk of morbidity and death associated
with both breast-feeding and not breast-feeding, and what
impact the recommendation and/or provision of formula
milk or other replacement feeds to HIV-infected women
will have on the feeding practices of uninfected mothers. 
Breast-milk fulfils the infant's total nutrient requirements
for the first 6 months of life and remains a valuable source
of nutrition up to 2 years and beyond.  Breast-feeding is
obviously the most economical and safe mode of infant
feeding, is important in promoting the mother-infant
relationship, and may enhance the child's intellectual
development.6 The more well-known benefit of breast-
feeding to the infant is reduction of the risk of infection,
especially infections resulting in diarrhoea and pneumonia,
and this has been reinforced by a recent meta-analysis.14 In
this meta-analysis, which included studies from Brazil,
Pakistan and the Philippines, breast-feeding was shown to
protect against child mortality especially in the early
months (odds ratios were 5.8, 4.1 and 2.8 for infants 0 - 2,
3 - 4 and 5 - 6 months of age respectively). The odds ratios
for protection against death from diarrhoea and acute
respiratory infections in the first 6 months of life were 6.1
and 1.9, respectively.  The authors concluded that ‘it will be
difficult, if not impossible, to provide safe breastmilk
substitutes to children from underprivileged populations’.  
The benefits of breast-feeding in terms of reduction of
mortality from infections are unlikely to be as important in
well-resourced developed communities where the risks of
artificial feeding can be minimised.  However, even in
Strong evidence Limited evidence
High plasma viral load Non-exclusive breast-feeding in the first 6 months 
Advanced disease/low CD4 count High breast-milk viral load 
Breast pathology — mastitis, abscesses, Subclinical mastitis as evidenced by increased breast-milk sodium levels
cracked or bleeding nipples 
Primary infection/new infection 
Prolonged duration of breast-feeding — Low maternal levels of vitamins B, C and E 
more than 6 months Infant oral candidiasis
RISK FACTORS FOR BREAST-FEEDING TRANSMISSION OF HIV
IMPACT OF BREAST-FEEDING ON THE HIV-INFECTED
MOTHER
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developed countries breast-feeding may protect against
bacterial and viral infections and later onset of health
problems such as diabetes, cardiovascular disease and
cancer. 
Because of the paucity of well-designed prospective trials
evaluating the long-term relative risks associated with
breast-feeding and formula-feeding in settings of high HIV
prevalence, several groups have designed mathematical
models to assess the net mortality.  In a recent modelling
exercise Kuhn et al.15 estimate that when infant mortality
rates are greater than about 40/1 000 live births, providing
formula milk to HIV-infected women would result in the
excess number of deaths arising from formula use being
approximately the same or greater than the number of HIV
infections that might be prevented. 
Counselling and empowering women to make an informed
choice on infant feeding is not simply a matter of
informing or educating them about the theoretical risks
and different feeding options.  Health workers need to
assess the individual mother's circumstances to ascertain
what is most feasible and safe for her. Time is required to
explain the factors that increase breast-feeding
transmission or morbidity from replacement feeds and
suggestions to reduce these risks.  In addition to a deep
understanding of the social issues and the household
situation, counsellors need to have the ability to translate
complex scientific concepts on risk in a way that can be
understood by women who do not grasp these dilemmas.
They need to express compassion and have the ability to
emotionally support women in a decision that affects
themselves, their children, and the rest of their family.16
Experience has shown that quality of counselling needs to
be prioritised in all programmes if women are to be assisted
to make informed choices.17
Now that there is growing evidence that mixed breast-
feeding carries considerable risk for HIV transmission, those
implementing PMTCT programmes should be cautious
about the distribution of free formula milk, as this practice
seems to encourage mixed breast-feeding.17,18 If
programmes are intent on providing free formula, a more
equitable and safer approach would be to provide a choice
of either formula milk for the infant or an equivalent value
of food vouchers for the mother.
For those mothers who choose exclusive breast-feeding, a
second choice will need to be made at about 6 months of
age.  The guidance that should be given at this stage is that
if the child is infected or suspected to be infected, the child
should continue being breast-fed. If the child is uninfected,
and provided that the child will have access to adequate
complementary food, the mother should be encouraged to
stop breast-feeding in a short period of about 1 - 2 weeks.
Mothers should be provided with specific guidance and
support when they cease breast-feeding to avoid harmful
nutritional and psychological consequences to the infant
and to maintain their breast health.  If the infant will not
have access to adequate complementary food, the best
option is probably for the mother to express and heat-treat
her breast-milk,19 and rather spend the money that would
have been spent on formula milk on complementary food.
Until more data are available to inform these issues, what
can be done to minimise breast-feeding transmission and
optimise child survival? Counselling skills and opportunities
should be improved so that health workers are more able to
assist women to make informed choices that they are
committed to follow.  For women who choose or need to
breast-feed, experienced support should be available to
ensure good exclusive breast-feeding practices so as to
minimise breast pathology, HIV viral load and disruptions to
the gut environment, and therefore to reduce risk of HIV
transmission.  Breast-feeding should be discouraged for
those women who have progressed to AIDS and have very
low CD4 counts. 
Strategies that should be employed to minimise risk of
transmission include the following:
■ Exclusive breast-feeding during the first 6 months.
■ A shorter duration of breast-feeding — about 6 months.
■ Good lactation management must be provided, so that
breast-feeding problems such as cracked nipples,
engorgement and mastitis are prevented.
■ If the mother does develop mastitis or abscesses, she
must express milk from the affected side frequently and
discard it, and continue feeding from the unaffected
side.
■ Condoms must be used throughout the lactation
period.
■ If the infant has oral thrush it must be treated promptly.
Pasteurisation of expressed breast-milk, using a method
that is practical and feasible even at home, can be used to
effectively kill all cell-free HIV.19 This strategy is likely to be
difficult to implement from birth but may be more relevant
after 6 months or as a temporary measure to sustain
exclusive breast-feeding where the mother is unwell or
away from her child. 
For those mothers who choose replacement feeding,
support should be available to demonstrate preparation
and safe storage of commercial infant formula to minimise
the risks of diarrhoeal morbidity and malnutrition.
MAKING INFORMED CHOICES ON INFANT FEEDING
STRATEGIES TO REDUCE BREAST-FEEDING
TRANSMISSION AND IMPROVE CHILD SURVIVAL
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Communities need to be engaged to be supportive of
mothers with HIV infection and accept the varied
approaches to infant feeding that may occur.
Recent animal trials and clinical trials suggest that
antiretrovirals given to the infant during the first few
weeks after delivery may protect the infant from HIV
transmission during the breast-feeding period.  In order to
provide more conclusive evidence on the efficacy of
antiretrovirals given to the infant, several studies are
currently underway testing the use of single or dual
antiretroviral drug regimens given for periods from 1 week
to 6 months.20
BREAST-FEEDING IN THE HIGHLY ACTIVE
ANTIRETROVIRAL THERAPY (HAART) SETTING
As already mentioned, maternal HIV viral load has
consistently been shown to be an important risk factor for
breast-feeding transmission.  It therefore seems very likely
that giving HAART to the mother during the lactation
period could reduce transmission.  For women in the
developing world, providing HAART during the pregnancy
and lactation period is emerging as a cost-effective option
that is currently under investigation in several trials.20 It is
likely that in the near future many women may already be
on HAART, and the question that is often posed is: ‘Can a
woman on HAART safely breast-feed?’  Unfortunately we
do not yet have enough information to answer this
question definitively, and can only suggest that given that
the viral load in women on HAART will be very low (at
undetectable levels), there should be no or minimal risk of
breast-feeding transmission.  Other considerations to bear
in mind in this decision would be safety issues.  We know
that most antiretrovirals will be excreted into the breast-
milk and the infant will be exposed to small quantities.  For
those drugs that have been widely used in infants, such as
nevirapine (NVP), zidovudine (ZDV) and lamivudine (3TC),
there are unlikely to be safety concerns.  The most obvious
concern will be the fact that infants will be exposed to
subtherapeutic levels of antiretrovirals through the breast-
milk, and if some infants escape protection and become
HIV-infected, they may have developed resistance to the
drugs used that will impact on their future HIV treatment.
Several trials are currently investigating these issues.20
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USE OF ANTIRETROVIRALS TO PROVIDE INFANT
PROPHYLAXIS DURING BREAST-FEEDING 
I would like to thank Professor Raziya Bobat,
Department of Paediatrics and Child Health, Nelson R
Mandela School of Medicine, University of KwaZulu-
Natal, for reviewing the manuscript and making helpful
comments.
